Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lenvatinib causes reduced expression of carnitine/organic cation transporter 2 and carnitine deficiency in the skeletal muscle of rats. | Toxicol Lett | 2022 | 35788046 | PubTator, text mining | PubMed |
| Impact of Metformin Treatment on Human Placental Energy Production and Oxidative Stress. | Front Cell Dev Biol | 2022 | 35784487 | PubTator, text mining | PubMed |
| Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington's disease. | Fluids Barriers CNS | 2022 | 35773691 | PubTator, text mining | PubMed |
| Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations. | Cancer Chemother Pharmacol | 2022 | 35771259 | PubTator, text mining | PubMed |
| BAGEL: A BAYESIAN GRAPHICAL MODEL FOR INFERRING DRUG EFFECT LONGITUDINALLY ON DEPRESSION IN PEOPLE WITH HIV. | Ann Appl Stat | 2022 | 35765300 | PubTator, text mining | PubMed |
| Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19. | Chem Zvesti | 2022 | 35757111 | PubTator, text mining | PubMed |
| Targeted Cancer Therapies Causing Elevations in Serum Creatinine Through Tubular Secretion Inhibition: A Case Report and Review of the Literature. | Can J Kidney Health Dis | 2022 | 35756332 | PubTator, text mining | PubMed |
| Prescribing for patients taking antiretroviral therapy. | Aust Prescr | 2022 | 35755990 | PubTator, text mining | PubMed |
| Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. | Acta Pharm Sin B | 2022 | 35755285 | PubTator, text mining | PubMed |
| High Affinity Decynium-22 Binding to Brain Membrane Homogenates and Reduced Dorsal Camouflaging after Acute Exposure to it in Zebrafish. | Front Pharmacol | 2022 | 35754508 | PubTator, text mining | PubMed |
| Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs). | Pharmaceutics | 2022 | 35745806 | PubTator, text mining | PubMed |
| Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19? | Pharmaceuticals (Basel) | 2022 | 35745658 | PubTator, text mining | PubMed |
| Acridone Derivatives from Atalantia monophyla Inhibited Cancer Cell Proliferation through ERK Pathway. | Molecules | 2022 | 35744993 | PubTator, text mining | PubMed |
| Genome-Wide Analyses of Nephrotoxicity in Platinum-Treated Cancer Patients Identify Association with Genetic Variant in RBMS3 and Acute Kidney Injury. | J Pers Med | 2022 | 35743677 | PubTator, text mining | PubMed |
| Pyrazolone-type compounds: synthesis and in silico assessment of antiviral potential against key viral proteins of SARS-CoV-2. | RSC Adv | 2022 | 35733695 | PubTator, text mining | PubMed |
| Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts. | J Neurol Neurosurg Psychiatry | 2022 | 35732412 | PubTator, text mining | PubMed |
| Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro. | PLoS One | 2022 | 35709159 | PubTator, text mining | PubMed |
| Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach. | Glob Med Genet | 2022 | 35707783 | PubTator, text mining | PubMed |
| Clonidine ameliorates cisplatin-induced nephrotoxicity: impact on OCT2 and p38 MAPK pathway. | J Pharm Pharmacol | 2022 | 35704284 | PubTator, text mining | PubMed |
| Evaluation of Physicochemical Properties, Pharmacokinetics, Biodistribution, Toxicity, and Contrast-Enhanced Cancer MRI of a Cancer-Targeting Contrast Agent, MT218. | Invest Radiol | 2022 | 35703463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=26